| 1st Feb 2017 11:02 am |
RNS |
Total Voting Rights |
| 25th Jan 2017 4:17 pm |
RNS |
Director/PDMR Shareholding |
| 24th Jan 2017 4:51 pm |
RNS |
Director/PDMR Shareholding |
| 23rd Jan 2017 3:45 pm |
RNS |
Director/PDMR Shareholding |
| 20th Jan 2017 3:07 pm |
RNS |
Director/PDMR Shareholding |
| 19th Jan 2017 7:05 am |
RNS |
Corporate executive team changes |
| 19th Jan 2017 7:00 am |
RNS |
Corporate executive team changes |
| 16th Jan 2017 6:25 pm |
RNS |
Director/PDMR Shareholding |
| 16th Jan 2017 6:08 pm |
RNS |
Director/PDMR Shareholding |
| 16th Jan 2017 5:15 pm |
RNS |
Director/PDMR Shareholding |
| 16th Jan 2017 5:04 pm |
RNS |
Director/PDMR Shareholding |
| 16th Jan 2017 4:54 pm |
RNS |
Director/PDMR Shareholding |
| 16th Jan 2017 4:01 pm |
RNS |
Director/PDMR Shareholding |
| 16th Jan 2017 3:51 pm |
RNS |
Director/PDMR Shareholding |
| 13th Jan 2017 4:40 pm |
RNS |
Director/PDMR Shareholding |
| 13th Jan 2017 3:44 pm |
RNS |
Director/PDMR Shareholding |
| 13th Jan 2017 2:29 pm |
RNS |
Director/PDMR Shareholding |
| 12th Jan 2017 4:38 pm |
RNS |
Director/PDMR Shareholding |
| 10th Jan 2017 4:51 pm |
RNS |
Director/PDMR Shareholding |
| 3rd Jan 2017 10:34 am |
RNS |
Total Voting Rights |
| 20th Dec 2016 2:03 pm |
RNS |
ViiV starts HIV prevention study with cabotegravir |
| 20th Dec 2016 7:17 am |
RNS |
Blocklisting Application |
| 20th Dec 2016 7:00 am |
RNS |
ViiV announce phase III results for 2-drug regimen |
| 19th Dec 2016 3:19 pm |
RNS |
Directorate Change |
| 19th Dec 2016 9:32 am |
RNS |
Phase III study start for closed triple in asthma |
| 16th Dec 2016 5:32 pm |
RNS |
Treasury Stock |
| 16th Dec 2016 10:45 am |
RNS |
Director/PDMR Shareholding |
| 13th Dec 2016 9:11 am |
RNS |
Audit Tender Conclusion |
| 12th Dec 2016 3:56 pm |
RNS |
Director/PDMR Shareholding |
| 2nd Dec 2016 3:49 pm |
RNS |
Director/PDMR Shareholding |
| 2nd Dec 2016 2:19 pm |
RNS |
GSK files closed triple therapy for COPD in EU |
| 2nd Dec 2016 7:01 am |
RNS |
Relvar Ellipta approved in Japan for COPD |
| 1st Dec 2016 11:00 am |
RNS |
Total Voting Rights |
| 30th Nov 2016 4:52 pm |
RNS |
Director/PDMR Shareholding |
| 25th Nov 2016 1:35 pm |
RNS |
EU submission of shingles candidate vaccine |
| 24th Nov 2016 11:07 am |
RNS |
Start of Phase III studies with daprodustat |
| 23rd Nov 2016 7:05 am |
RNS |
Mepolizumab meets endpoints in phase 3 EGPA study |
| 21st Nov 2016 7:02 am |
RNS |
GSK files closed triple therapy for COPD in US |
| 18th Nov 2016 2:40 pm |
RNS |
ViiV starts PhIII LA injectable treatment regimen |
| 16th Nov 2016 4:04 pm |
RNS |
New phase III data of sirukumab for RA |
